omega-n-methylarginine has been researched along with isoniazid in 1 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (isoniazid) | Trials (isoniazid) | Recent Studies (post-2010) (isoniazid) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 21,815 | 960 | 4,493 |
| Protein | Taxonomy | omega-n-methylarginine (IC50) | isoniazid (IC50) |
|---|---|---|---|
| Myeloperoxidase | Homo sapiens (human) | 4.85 | |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | Mycobacterium tuberculosis H37Rv | 8.29 | |
| Putative FAD-containing monooxygenase MymA | Mycobacterium tuberculosis H37Rv | 4.9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arnold, RE; Weigent, DA | 1 |
1 other study(ies) available for omega-n-methylarginine and isoniazid
| Article | Year |
|---|---|
The inhibition of superoxide production in EL4 lymphoma cells overexpressing growth hormone.
Topics: Animals; Apoptosis; Blotting, Western; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP2E1 Inhibitors; Enzyme Inhibitors; Flow Cytometry; Fluorometry; Growth Hormone; Isoniazid; Lymphoma, T-Cell; Mice; NADPH Oxidases; omega-N-Methylarginine; Superoxides; T-Lymphocytes; Tumor Cells, Cultured; Xanthine Oxidase | 2003 |